Back to top

Image: Bigstock

BioDelivery Sciences (BDSI) in Focus: Stock Moves 5.1% Higher

Read MoreHide Full Article

BioDelivery Sciences International, Inc. was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.95–$2.25 in the past one-month time frame, witnessed a sharp increase yesterday.

BioDelivery Sciences has seen the Zacks Consensus Estimate for the current quarter being revised downward over the past two months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.  

BioDelivery Sciences currently has a Zacks Rank #3 (Hold) while its Earnings ESPis 0.00%.

BioDelivery Sciences International, Inc. Price and Consensus

Another stock in the   Medical - Biomedical and Genetics industry is Protagonist Therapeutics, Inc. (PTGX - Free Report) which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BDSI going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>

 


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Protagonist Therapeutics, Inc. (PTGX) - free report >>

Published in